Yamazaki N, Kiyohara Y, Uhara H, Tsuchida T, et al. Real-world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance. J Dermatol 2020 Jun 8. doi: 10.1111/1346-8138.15388.
PMID: 32515086